Cargando…
Long-Term prognosis of radiofrequency catheter ablation for atrial fibrillation with different subtypes of heart failure in the era of ablation index guidance
BACKGROUND: The long-term outcomes of ablation index (AI)-guided radiofrequency catheter ablation (RFCA) on atrial fibrillation (AF) and different subtypes of heart failure (HF) remain unknown. The aim of the study was to evaluate the long-term prognosis of AI-guided RFCA procedures in patients with...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9530740/ https://www.ncbi.nlm.nih.gov/pubmed/36204561 http://dx.doi.org/10.3389/fcvm.2022.922910 |
_version_ | 1784801752392925184 |
---|---|
author | Qiao, Yu Zhao, Zhen Cai, Xiang Guo, Yulong Fu, Mingpeng Liu, Ke Guo, Jinrui Guo, Tao Niu, Guodong |
author_facet | Qiao, Yu Zhao, Zhen Cai, Xiang Guo, Yulong Fu, Mingpeng Liu, Ke Guo, Jinrui Guo, Tao Niu, Guodong |
author_sort | Qiao, Yu |
collection | PubMed |
description | BACKGROUND: The long-term outcomes of ablation index (AI)-guided radiofrequency catheter ablation (RFCA) on atrial fibrillation (AF) and different subtypes of heart failure (HF) remain unknown. The aim of the study was to evaluate the long-term prognosis of AI-guided RFCA procedures in patients with AF and concomitant HF. METHODS: We retrospectively included consecutive patients with AF and HF who underwent the initial RFCA procedure with AI guidance from March 2018 to June 2021 in our institution. The patients were categorized into two groups: HF with preserved ejection fraction (HFpEF) group and HF with mid-range ejection fraction (HFmrEF) +HF with reduced ejection fraction (HFrEF) group. RESULTS: A total of 101 patients were included. HFpEF and HFmrEF + HFrEF groups consisted of 71 (70.3%) and 30 patients (29.7%), respectively. During a median follow-up of 32.0 (18.2, 37.6) months, no significant difference was detected in AF recurrence between groups (21.1 vs. 33.3%) after multiple procedures, whereas the incidence of the composite endpoint of all-cause death, thromboembolic events, and HF hospitalization was significantly lower in HFpEF group (9.9 vs. 25.0%, Log-rank p = 0.018). In multivariable analysis, a history of hypertension [hazard ratio (HR) 4.667, 95% confidence interval (CI) 1.433–15.203, p = 0.011], left ventricular ejection fraction (LVEF) < 50% (HR 5.390, 95% CI 1.911–15.203, p = 0.001) and recurrent AF after multiple procedures (HR 7.542, 95% CI 2.355–24.148, p = 0.001) were independently associated with the incidence of the composite endpoint. CONCLUSION: Long-term success could be achieved in 75% of patients with AF and concomitant HF after AI-guided RFCA procedures, irrespective of different HF subtypes. Preserved LVEF was associated with a reduction in the composite endpoint compared with impaired LVEF. Patients with recurrent AF tend to have a poorer prognosis. |
format | Online Article Text |
id | pubmed-9530740 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-95307402022-10-05 Long-Term prognosis of radiofrequency catheter ablation for atrial fibrillation with different subtypes of heart failure in the era of ablation index guidance Qiao, Yu Zhao, Zhen Cai, Xiang Guo, Yulong Fu, Mingpeng Liu, Ke Guo, Jinrui Guo, Tao Niu, Guodong Front Cardiovasc Med Cardiovascular Medicine BACKGROUND: The long-term outcomes of ablation index (AI)-guided radiofrequency catheter ablation (RFCA) on atrial fibrillation (AF) and different subtypes of heart failure (HF) remain unknown. The aim of the study was to evaluate the long-term prognosis of AI-guided RFCA procedures in patients with AF and concomitant HF. METHODS: We retrospectively included consecutive patients with AF and HF who underwent the initial RFCA procedure with AI guidance from March 2018 to June 2021 in our institution. The patients were categorized into two groups: HF with preserved ejection fraction (HFpEF) group and HF with mid-range ejection fraction (HFmrEF) +HF with reduced ejection fraction (HFrEF) group. RESULTS: A total of 101 patients were included. HFpEF and HFmrEF + HFrEF groups consisted of 71 (70.3%) and 30 patients (29.7%), respectively. During a median follow-up of 32.0 (18.2, 37.6) months, no significant difference was detected in AF recurrence between groups (21.1 vs. 33.3%) after multiple procedures, whereas the incidence of the composite endpoint of all-cause death, thromboembolic events, and HF hospitalization was significantly lower in HFpEF group (9.9 vs. 25.0%, Log-rank p = 0.018). In multivariable analysis, a history of hypertension [hazard ratio (HR) 4.667, 95% confidence interval (CI) 1.433–15.203, p = 0.011], left ventricular ejection fraction (LVEF) < 50% (HR 5.390, 95% CI 1.911–15.203, p = 0.001) and recurrent AF after multiple procedures (HR 7.542, 95% CI 2.355–24.148, p = 0.001) were independently associated with the incidence of the composite endpoint. CONCLUSION: Long-term success could be achieved in 75% of patients with AF and concomitant HF after AI-guided RFCA procedures, irrespective of different HF subtypes. Preserved LVEF was associated with a reduction in the composite endpoint compared with impaired LVEF. Patients with recurrent AF tend to have a poorer prognosis. Frontiers Media S.A. 2022-09-20 /pmc/articles/PMC9530740/ /pubmed/36204561 http://dx.doi.org/10.3389/fcvm.2022.922910 Text en Copyright © 2022 Qiao, Zhao, Cai, Guo, Fu, Liu, Guo, Guo and Niu. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Cardiovascular Medicine Qiao, Yu Zhao, Zhen Cai, Xiang Guo, Yulong Fu, Mingpeng Liu, Ke Guo, Jinrui Guo, Tao Niu, Guodong Long-Term prognosis of radiofrequency catheter ablation for atrial fibrillation with different subtypes of heart failure in the era of ablation index guidance |
title | Long-Term prognosis of radiofrequency catheter ablation for atrial fibrillation with different subtypes of heart failure in the era of ablation index guidance |
title_full | Long-Term prognosis of radiofrequency catheter ablation for atrial fibrillation with different subtypes of heart failure in the era of ablation index guidance |
title_fullStr | Long-Term prognosis of radiofrequency catheter ablation for atrial fibrillation with different subtypes of heart failure in the era of ablation index guidance |
title_full_unstemmed | Long-Term prognosis of radiofrequency catheter ablation for atrial fibrillation with different subtypes of heart failure in the era of ablation index guidance |
title_short | Long-Term prognosis of radiofrequency catheter ablation for atrial fibrillation with different subtypes of heart failure in the era of ablation index guidance |
title_sort | long-term prognosis of radiofrequency catheter ablation for atrial fibrillation with different subtypes of heart failure in the era of ablation index guidance |
topic | Cardiovascular Medicine |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9530740/ https://www.ncbi.nlm.nih.gov/pubmed/36204561 http://dx.doi.org/10.3389/fcvm.2022.922910 |
work_keys_str_mv | AT qiaoyu longtermprognosisofradiofrequencycatheterablationforatrialfibrillationwithdifferentsubtypesofheartfailureintheeraofablationindexguidance AT zhaozhen longtermprognosisofradiofrequencycatheterablationforatrialfibrillationwithdifferentsubtypesofheartfailureintheeraofablationindexguidance AT caixiang longtermprognosisofradiofrequencycatheterablationforatrialfibrillationwithdifferentsubtypesofheartfailureintheeraofablationindexguidance AT guoyulong longtermprognosisofradiofrequencycatheterablationforatrialfibrillationwithdifferentsubtypesofheartfailureintheeraofablationindexguidance AT fumingpeng longtermprognosisofradiofrequencycatheterablationforatrialfibrillationwithdifferentsubtypesofheartfailureintheeraofablationindexguidance AT liuke longtermprognosisofradiofrequencycatheterablationforatrialfibrillationwithdifferentsubtypesofheartfailureintheeraofablationindexguidance AT guojinrui longtermprognosisofradiofrequencycatheterablationforatrialfibrillationwithdifferentsubtypesofheartfailureintheeraofablationindexguidance AT guotao longtermprognosisofradiofrequencycatheterablationforatrialfibrillationwithdifferentsubtypesofheartfailureintheeraofablationindexguidance AT niuguodong longtermprognosisofradiofrequencycatheterablationforatrialfibrillationwithdifferentsubtypesofheartfailureintheeraofablationindexguidance |